Other Consolidated Financial Statement - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 25.1 | $ (3.2) | $ (36.8) | $ 32.5 | |
| Prepaid Taxes | 943.7 | 943.7 | $ 693.6 | ||
| Other liabilities, noncurrent | 668.4 | 668.4 | 748.5 | ||
| Accrued income taxes | 179.1 | 179.1 | $ 166.4 | ||
| Sage and Denali | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 3.8 | ||||
| Denali Therapeutics | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 23.7 | $ 42.2 | 41.9 | ||
| Sage Therapeutics | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 23.0 | ||||